Načítá se...
An Update of Prophylactic Human Papillomavirus L1 Virus-Like Particle Vaccine Clinical Trial Results
This review focuses on recent publications of clinical trials of two prophylactic Human Papillomavirus (HPV) vaccines: Gardasil® (Merck & Co., Whitehouse Station, NJ USA), a quadrivalent vaccine containing L1 virus-like particles (VLPs) of types −6, 11, 16, and 18, and Cervarix® (GlaxoSmithKline...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2631230/ https://ncbi.nlm.nih.gov/pubmed/18847557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.06.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|